English
Deutsch
Log In
Password Login
or
Log in with Fraunhofer Smartcard
Research Outputs
Projects
Researchers
Institutes
Statistics
Fraunhofer-Gesellschaft
Home
Fraunhofer-Gesellschaft
Artikel
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers
Details
Full
Export
Statistics
Options
2013
Journal Article
Titel
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers
Author(s)
Kirsten, A.
Watz, H.
Pedersen, F.
Holz, O.
Smith, R.
Bruin, G.
Koehne-Voss, S.
Magnussen, H.
Waltz, D.A.
Zeitschrift
European Respiratory Journal
DOI
10.1183/09031936.00123612
Language
English
google-scholar
View Details
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM
Tags
IL-17A
ozone exposure
lung diseases
antibody
monoclonal - therapeutic use